nodes	percent_of_prediction	percent_of_DWPC	metapath
Guanabenz—Arthralgia—Rosuvastatin—atherosclerosis	0.00211	0.00309	CcSEcCtD
Guanabenz—Myalgia—Rosuvastatin—atherosclerosis	0.00211	0.00309	CcSEcCtD
Guanabenz—Haemoglobin—Niacin—atherosclerosis	0.00208	0.00305	CcSEcCtD
Guanabenz—Haemorrhage—Niacin—atherosclerosis	0.00207	0.00303	CcSEcCtD
Guanabenz—Flatulence—Lovastatin—atherosclerosis	0.00207	0.00303	CcSEcCtD
Guanabenz—Malnutrition—Ezetimibe—atherosclerosis	0.00206	0.00301	CcSEcCtD
Guanabenz—Erythema—Ezetimibe—atherosclerosis	0.00206	0.00301	CcSEcCtD
Guanabenz—Oedema peripheral—Niacin—atherosclerosis	0.00204	0.00299	CcSEcCtD
Guanabenz—Confusional state—Rosuvastatin—atherosclerosis	0.00204	0.00298	CcSEcCtD
Guanabenz—Back pain—Lovastatin—atherosclerosis	0.00203	0.00297	CcSEcCtD
Guanabenz—Flatulence—Ezetimibe—atherosclerosis	0.00203	0.00297	CcSEcCtD
Guanabenz—Chills—Simvastatin—atherosclerosis	0.00203	0.00296	CcSEcCtD
Guanabenz—Muscle spasms—Lovastatin—atherosclerosis	0.00202	0.00295	CcSEcCtD
Guanabenz—Infection—Rosuvastatin—atherosclerosis	0.00201	0.00294	CcSEcCtD
Guanabenz—Back pain—Ezetimibe—atherosclerosis	0.00199	0.00291	CcSEcCtD
Guanabenz—Nervous system disorder—Rosuvastatin—atherosclerosis	0.00199	0.0029	CcSEcCtD
Guanabenz—Muscle spasms—Ezetimibe—atherosclerosis	0.00198	0.0029	CcSEcCtD
Guanabenz—Thrombocytopenia—Rosuvastatin—atherosclerosis	0.00198	0.0029	CcSEcCtD
Guanabenz—Vision blurred—Lovastatin—atherosclerosis	0.00198	0.00289	CcSEcCtD
Guanabenz—Erythema—Simvastatin—atherosclerosis	0.00197	0.00287	CcSEcCtD
Guanabenz—Ill-defined disorder—Lovastatin—atherosclerosis	0.00195	0.00285	CcSEcCtD
Guanabenz—Eye disorder—Niacin—atherosclerosis	0.00194	0.00283	CcSEcCtD
Guanabenz—Flatulence—Simvastatin—atherosclerosis	0.00194	0.00283	CcSEcCtD
Guanabenz—Tinnitus—Niacin—atherosclerosis	0.00193	0.00283	CcSEcCtD
Guanabenz—Erythema multiforme—Pravastatin—atherosclerosis	0.00193	0.00282	CcSEcCtD
Guanabenz—Angioedema—Lovastatin—atherosclerosis	0.00192	0.00281	CcSEcCtD
Guanabenz—Ill-defined disorder—Ezetimibe—atherosclerosis	0.00191	0.00279	CcSEcCtD
Guanabenz—Anaemia—Ezetimibe—atherosclerosis	0.00191	0.00278	CcSEcCtD
Guanabenz—Tinnitus—Pravastatin—atherosclerosis	0.0019	0.00278	CcSEcCtD
Guanabenz—Malaise—Lovastatin—atherosclerosis	0.0019	0.00277	CcSEcCtD
Guanabenz—Muscle spasms—Simvastatin—atherosclerosis	0.00189	0.00276	CcSEcCtD
Guanabenz—Angioedema—Ezetimibe—atherosclerosis	0.00188	0.00275	CcSEcCtD
Guanabenz—Leukopenia—Lovastatin—atherosclerosis	0.00188	0.00275	CcSEcCtD
Guanabenz—Chills—Niacin—atherosclerosis	0.00186	0.00272	CcSEcCtD
Guanabenz—Malaise—Ezetimibe—atherosclerosis	0.00186	0.00272	CcSEcCtD
Guanabenz—Vision blurred—Simvastatin—atherosclerosis	0.00185	0.00271	CcSEcCtD
Guanabenz—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.00184	0.00269	CcSEcCtD
Guanabenz—Chills—Pravastatin—atherosclerosis	0.00183	0.00268	CcSEcCtD
Guanabenz—Ill-defined disorder—Simvastatin—atherosclerosis	0.00182	0.00267	CcSEcCtD
Guanabenz—Paraesthesia—Rosuvastatin—atherosclerosis	0.00182	0.00266	CcSEcCtD
Guanabenz—Anaemia—Simvastatin—atherosclerosis	0.00182	0.00266	CcSEcCtD
Guanabenz—Erythema—Niacin—atherosclerosis	0.00181	0.00264	CcSEcCtD
Guanabenz—Malnutrition—Niacin—atherosclerosis	0.00181	0.00264	CcSEcCtD
Guanabenz—Cough—Ezetimibe—atherosclerosis	0.0018	0.00263	CcSEcCtD
Guanabenz—Angioedema—Simvastatin—atherosclerosis	0.0018	0.00262	CcSEcCtD
Guanabenz—Arthralgia—Lovastatin—atherosclerosis	0.00179	0.00261	CcSEcCtD
Guanabenz—Myalgia—Lovastatin—atherosclerosis	0.00179	0.00261	CcSEcCtD
Guanabenz—Chest pain—Lovastatin—atherosclerosis	0.00179	0.00261	CcSEcCtD
Guanabenz—Anxiety—Lovastatin—atherosclerosis	0.00178	0.00261	CcSEcCtD
Guanabenz—Dyspepsia—Rosuvastatin—atherosclerosis	0.00178	0.0026	CcSEcCtD
Guanabenz—Hypertension—Ezetimibe—atherosclerosis	0.00178	0.0026	CcSEcCtD
Guanabenz—Flatulence—Niacin—atherosclerosis	0.00178	0.0026	CcSEcCtD
Guanabenz—Malaise—Simvastatin—atherosclerosis	0.00177	0.00259	CcSEcCtD
Guanabenz—Tension—Niacin—atherosclerosis	0.00177	0.00259	CcSEcCtD
Guanabenz—Discomfort—Lovastatin—atherosclerosis	0.00177	0.00258	CcSEcCtD
Guanabenz—Leukopenia—Simvastatin—atherosclerosis	0.00176	0.00257	CcSEcCtD
Guanabenz—Chest pain—Ezetimibe—atherosclerosis	0.00176	0.00256	CcSEcCtD
Guanabenz—Myalgia—Ezetimibe—atherosclerosis	0.00176	0.00256	CcSEcCtD
Guanabenz—Arthralgia—Ezetimibe—atherosclerosis	0.00176	0.00256	CcSEcCtD
Guanabenz—Nervousness—Niacin—atherosclerosis	0.00175	0.00256	CcSEcCtD
Guanabenz—Flatulence—Pravastatin—atherosclerosis	0.00175	0.00256	CcSEcCtD
Guanabenz—Dry mouth—Lovastatin—atherosclerosis	0.00175	0.00256	CcSEcCtD
Guanabenz—Tension—Pravastatin—atherosclerosis	0.00174	0.00255	CcSEcCtD
Guanabenz—Muscle spasms—Niacin—atherosclerosis	0.00174	0.00254	CcSEcCtD
Guanabenz—Discomfort—Ezetimibe—atherosclerosis	0.00173	0.00253	CcSEcCtD
Guanabenz—Constipation—Rosuvastatin—atherosclerosis	0.00173	0.00253	CcSEcCtD
Guanabenz—Pain—Rosuvastatin—atherosclerosis	0.00173	0.00253	CcSEcCtD
Guanabenz—Confusional state—Lovastatin—atherosclerosis	0.00173	0.00253	CcSEcCtD
Guanabenz—Nervousness—Pravastatin—atherosclerosis	0.00173	0.00252	CcSEcCtD
Guanabenz—Dry mouth—Ezetimibe—atherosclerosis	0.00172	0.00251	CcSEcCtD
Guanabenz—Muscle spasms—Pravastatin—atherosclerosis	0.00171	0.0025	CcSEcCtD
Guanabenz—Infection—Lovastatin—atherosclerosis	0.0017	0.00249	CcSEcCtD
Guanabenz—Vision blurred—Niacin—atherosclerosis	0.0017	0.00249	CcSEcCtD
Guanabenz—Confusional state—Ezetimibe—atherosclerosis	0.0017	0.00248	CcSEcCtD
Guanabenz—Thrombocytopenia—Lovastatin—atherosclerosis	0.00168	0.00245	CcSEcCtD
Guanabenz—Vision blurred—Pravastatin—atherosclerosis	0.00168	0.00245	CcSEcCtD
Guanabenz—Chest pain—Simvastatin—atherosclerosis	0.00167	0.00245	CcSEcCtD
Guanabenz—Arthralgia—Simvastatin—atherosclerosis	0.00167	0.00245	CcSEcCtD
Guanabenz—Myalgia—Simvastatin—atherosclerosis	0.00167	0.00245	CcSEcCtD
Guanabenz—Infection—Ezetimibe—atherosclerosis	0.00167	0.00244	CcSEcCtD
Guanabenz—Feeling abnormal—Rosuvastatin—atherosclerosis	0.00167	0.00244	CcSEcCtD
Guanabenz—Anxiety—Simvastatin—atherosclerosis	0.00167	0.00244	CcSEcCtD
Guanabenz—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.00166	0.00242	CcSEcCtD
Guanabenz—Discomfort—Simvastatin—atherosclerosis	0.00165	0.00242	CcSEcCtD
Guanabenz—Nervous system disorder—Ezetimibe—atherosclerosis	0.00165	0.00241	CcSEcCtD
Guanabenz—Angioedema—Niacin—atherosclerosis	0.00165	0.00241	CcSEcCtD
Guanabenz—Ill-defined disorder—Pravastatin—atherosclerosis	0.00165	0.00241	CcSEcCtD
Guanabenz—Thrombocytopenia—Ezetimibe—atherosclerosis	0.00165	0.00241	CcSEcCtD
Guanabenz—Anaemia—Pravastatin—atherosclerosis	0.00164	0.0024	CcSEcCtD
Guanabenz—Anorexia—Lovastatin—atherosclerosis	0.00164	0.00239	CcSEcCtD
Guanabenz—Skin disorder—Ezetimibe—atherosclerosis	0.00163	0.00239	CcSEcCtD
Guanabenz—Angioedema—Pravastatin—atherosclerosis	0.00162	0.00237	CcSEcCtD
Guanabenz—Syncope—Niacin—atherosclerosis	0.00162	0.00237	CcSEcCtD
Guanabenz—Confusional state—Simvastatin—atherosclerosis	0.00162	0.00236	CcSEcCtD
Guanabenz—Leukopenia—Niacin—atherosclerosis	0.00162	0.00236	CcSEcCtD
Guanabenz—Urticaria—Rosuvastatin—atherosclerosis	0.00161	0.00235	CcSEcCtD
Guanabenz—Oedema—Simvastatin—atherosclerosis	0.0016	0.00234	CcSEcCtD
Guanabenz—Malaise—Pravastatin—atherosclerosis	0.0016	0.00234	CcSEcCtD
Guanabenz—Abdominal pain—Rosuvastatin—atherosclerosis	0.0016	0.00234	CcSEcCtD
Guanabenz—Infection—Simvastatin—atherosclerosis	0.00159	0.00233	CcSEcCtD
Guanabenz—Leukopenia—Pravastatin—atherosclerosis	0.00159	0.00232	CcSEcCtD
Guanabenz—Loss of consciousness—Niacin—atherosclerosis	0.00159	0.00232	CcSEcCtD
Guanabenz—Cough—Niacin—atherosclerosis	0.00158	0.0023	CcSEcCtD
Guanabenz—Thrombocytopenia—Simvastatin—atherosclerosis	0.00157	0.0023	CcSEcCtD
Guanabenz—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.00156	0.00228	CcSEcCtD
Guanabenz—Cough—Pravastatin—atherosclerosis	0.00155	0.00227	CcSEcCtD
Guanabenz—Paraesthesia—Lovastatin—atherosclerosis	0.00154	0.00225	CcSEcCtD
Guanabenz—Arthralgia—Niacin—atherosclerosis	0.00154	0.00225	CcSEcCtD
Guanabenz—Myalgia—Niacin—atherosclerosis	0.00154	0.00225	CcSEcCtD
Guanabenz—Hypertension—Pravastatin—atherosclerosis	0.00153	0.00224	CcSEcCtD
Guanabenz—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.00153	0.00224	CcSEcCtD
Guanabenz—Anorexia—Simvastatin—atherosclerosis	0.00153	0.00223	CcSEcCtD
Guanabenz—Dyspnoea—Lovastatin—atherosclerosis	0.00153	0.00223	CcSEcCtD
Guanabenz—Arthralgia—Pravastatin—atherosclerosis	0.00151	0.00221	CcSEcCtD
Guanabenz—Myalgia—Pravastatin—atherosclerosis	0.00151	0.00221	CcSEcCtD
Guanabenz—Chest pain—Pravastatin—atherosclerosis	0.00151	0.00221	CcSEcCtD
Guanabenz—Paraesthesia—Ezetimibe—atherosclerosis	0.00151	0.00221	CcSEcCtD
Guanabenz—Dyspepsia—Lovastatin—atherosclerosis	0.00151	0.00221	CcSEcCtD
Guanabenz—Anxiety—Pravastatin—atherosclerosis	0.00151	0.0022	CcSEcCtD
Guanabenz—Dry mouth—Niacin—atherosclerosis	0.0015	0.0022	CcSEcCtD
Guanabenz—Dyspnoea—Ezetimibe—atherosclerosis	0.0015	0.00219	CcSEcCtD
Guanabenz—Discomfort—Pravastatin—atherosclerosis	0.0015	0.00218	CcSEcCtD
Guanabenz—Hypersensitivity—Rosuvastatin—atherosclerosis	0.00149	0.00218	CcSEcCtD
Guanabenz—Decreased appetite—Lovastatin—atherosclerosis	0.00149	0.00218	CcSEcCtD
Guanabenz—Dyspepsia—Ezetimibe—atherosclerosis	0.00148	0.00216	CcSEcCtD
Guanabenz—Fatigue—Lovastatin—atherosclerosis	0.00148	0.00216	CcSEcCtD
Guanabenz—Oedema—Niacin—atherosclerosis	0.00147	0.00215	CcSEcCtD
Guanabenz—Pain—Lovastatin—atherosclerosis	0.00147	0.00214	CcSEcCtD
Guanabenz—Constipation—Lovastatin—atherosclerosis	0.00147	0.00214	CcSEcCtD
Guanabenz—Confusional state—Pravastatin—atherosclerosis	0.00146	0.00214	CcSEcCtD
Guanabenz—Decreased appetite—Ezetimibe—atherosclerosis	0.00146	0.00214	CcSEcCtD
Guanabenz—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.00146	0.00214	CcSEcCtD
Guanabenz—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.00145	0.00212	CcSEcCtD
Guanabenz—Asthenia—Rosuvastatin—atherosclerosis	0.00145	0.00212	CcSEcCtD
Guanabenz—Oedema—Pravastatin—atherosclerosis	0.00145	0.00212	CcSEcCtD
Guanabenz—Fatigue—Ezetimibe—atherosclerosis	0.00145	0.00212	CcSEcCtD
Guanabenz—Shock—Niacin—atherosclerosis	0.00145	0.00212	CcSEcCtD
Guanabenz—Infection—Pravastatin—atherosclerosis	0.00144	0.00211	CcSEcCtD
Guanabenz—Paraesthesia—Simvastatin—atherosclerosis	0.00144	0.00211	CcSEcCtD
Guanabenz—Pain—Ezetimibe—atherosclerosis	0.00144	0.0021	CcSEcCtD
Guanabenz—Constipation—Ezetimibe—atherosclerosis	0.00144	0.0021	CcSEcCtD
Guanabenz—Tachycardia—Niacin—atherosclerosis	0.00144	0.0021	CcSEcCtD
Guanabenz—Pruritus—Rosuvastatin—atherosclerosis	0.00143	0.00209	CcSEcCtD
Guanabenz—Skin disorder—Niacin—atherosclerosis	0.00143	0.00209	CcSEcCtD
Guanabenz—Dyspnoea—Simvastatin—atherosclerosis	0.00143	0.00209	CcSEcCtD
Guanabenz—Thrombocytopenia—Pravastatin—atherosclerosis	0.00142	0.00208	CcSEcCtD
Guanabenz—Feeling abnormal—Lovastatin—atherosclerosis	0.00141	0.00207	CcSEcCtD
Guanabenz—Dyspepsia—Simvastatin—atherosclerosis	0.00141	0.00206	CcSEcCtD
Guanabenz—Anorexia—Niacin—atherosclerosis	0.0014	0.00205	CcSEcCtD
Guanabenz—Gastrointestinal pain—Lovastatin—atherosclerosis	0.0014	0.00205	CcSEcCtD
Guanabenz—Decreased appetite—Simvastatin—atherosclerosis	0.00139	0.00204	CcSEcCtD
Guanabenz—Feeling abnormal—Ezetimibe—atherosclerosis	0.00139	0.00203	CcSEcCtD
Guanabenz—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.00139	0.00202	CcSEcCtD
Guanabenz—Diarrhoea—Rosuvastatin—atherosclerosis	0.00138	0.00202	CcSEcCtD
Guanabenz—Fatigue—Simvastatin—atherosclerosis	0.00138	0.00202	CcSEcCtD
Guanabenz—Anorexia—Pravastatin—atherosclerosis	0.00138	0.00202	CcSEcCtD
Guanabenz—Hypotension—Niacin—atherosclerosis	0.00138	0.00201	CcSEcCtD
Guanabenz—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.00138	0.00201	CcSEcCtD
Guanabenz—Constipation—Simvastatin—atherosclerosis	0.00137	0.002	CcSEcCtD
Guanabenz—Pain—Simvastatin—atherosclerosis	0.00137	0.002	CcSEcCtD
Guanabenz—Urticaria—Lovastatin—atherosclerosis	0.00136	0.00199	CcSEcCtD
Guanabenz—Abdominal pain—Lovastatin—atherosclerosis	0.00136	0.00198	CcSEcCtD
Guanabenz—Body temperature increased—Lovastatin—atherosclerosis	0.00136	0.00198	CcSEcCtD
Guanabenz—Musculoskeletal discomfort—Niacin—atherosclerosis	0.00134	0.00196	CcSEcCtD
Guanabenz—Dizziness—Rosuvastatin—atherosclerosis	0.00134	0.00196	CcSEcCtD
Guanabenz—Urticaria—Ezetimibe—atherosclerosis	0.00134	0.00195	CcSEcCtD
Guanabenz—Abdominal pain—Ezetimibe—atherosclerosis	0.00133	0.00194	CcSEcCtD
Guanabenz—Body temperature increased—Ezetimibe—atherosclerosis	0.00133	0.00194	CcSEcCtD
Guanabenz—Paraesthesia—Niacin—atherosclerosis	0.00132	0.00193	CcSEcCtD
Guanabenz—Feeling abnormal—Simvastatin—atherosclerosis	0.00132	0.00193	CcSEcCtD
Guanabenz—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.00132	0.00193	CcSEcCtD
Guanabenz—Dyspnoea—Niacin—atherosclerosis	0.00131	0.00192	CcSEcCtD
Guanabenz—Gastrointestinal pain—Simvastatin—atherosclerosis	0.00131	0.00192	CcSEcCtD
Guanabenz—Paraesthesia—Pravastatin—atherosclerosis	0.0013	0.0019	CcSEcCtD
Guanabenz—Dyspepsia—Niacin—atherosclerosis	0.0013	0.0019	CcSEcCtD
Guanabenz—Dyspnoea—Pravastatin—atherosclerosis	0.00129	0.00189	CcSEcCtD
Guanabenz—Decreased appetite—Niacin—atherosclerosis	0.00128	0.00187	CcSEcCtD
Guanabenz—Dyspepsia—Pravastatin—atherosclerosis	0.00128	0.00187	CcSEcCtD
Guanabenz—Rash—Rosuvastatin—atherosclerosis	0.00128	0.00186	CcSEcCtD
Guanabenz—Dermatitis—Rosuvastatin—atherosclerosis	0.00128	0.00186	CcSEcCtD
Guanabenz—Urticaria—Simvastatin—atherosclerosis	0.00127	0.00186	CcSEcCtD
Guanabenz—Gastrointestinal disorder—Niacin—atherosclerosis	0.00127	0.00186	CcSEcCtD
Guanabenz—Abdominal pain—Simvastatin—atherosclerosis	0.00127	0.00185	CcSEcCtD
Guanabenz—Body temperature increased—Simvastatin—atherosclerosis	0.00127	0.00185	CcSEcCtD
Guanabenz—Headache—Rosuvastatin—atherosclerosis	0.00127	0.00185	CcSEcCtD
Guanabenz—Hypersensitivity—Lovastatin—atherosclerosis	0.00126	0.00185	CcSEcCtD
Guanabenz—Decreased appetite—Pravastatin—atherosclerosis	0.00126	0.00184	CcSEcCtD
Guanabenz—Pain—Niacin—atherosclerosis	0.00126	0.00184	CcSEcCtD
Guanabenz—Fatigue—Pravastatin—atherosclerosis	0.00125	0.00183	CcSEcCtD
Guanabenz—Pain—Pravastatin—atherosclerosis	0.00124	0.00181	CcSEcCtD
Guanabenz—Constipation—Pravastatin—atherosclerosis	0.00124	0.00181	CcSEcCtD
Guanabenz—Hypersensitivity—Ezetimibe—atherosclerosis	0.00124	0.00181	CcSEcCtD
Guanabenz—Asthenia—Lovastatin—atherosclerosis	0.00123	0.0018	CcSEcCtD
Guanabenz—Pruritus—Lovastatin—atherosclerosis	0.00121	0.00177	CcSEcCtD
Guanabenz—Asthenia—Ezetimibe—atherosclerosis	0.00121	0.00176	CcSEcCtD
Guanabenz—Gastrointestinal pain—Niacin—atherosclerosis	0.0012	0.00176	CcSEcCtD
Guanabenz—Nausea—Rosuvastatin—atherosclerosis	0.0012	0.00176	CcSEcCtD
Guanabenz—Feeling abnormal—Pravastatin—atherosclerosis	0.0012	0.00175	CcSEcCtD
Guanabenz—Pruritus—Ezetimibe—atherosclerosis	0.00119	0.00174	CcSEcCtD
Guanabenz—Gastrointestinal pain—Pravastatin—atherosclerosis	0.00119	0.00173	CcSEcCtD
Guanabenz—Hypersensitivity—Simvastatin—atherosclerosis	0.00118	0.00173	CcSEcCtD
Guanabenz—Diarrhoea—Lovastatin—atherosclerosis	0.00117	0.00172	CcSEcCtD
Guanabenz—Urticaria—Niacin—atherosclerosis	0.00117	0.00171	CcSEcCtD
Guanabenz—Abdominal pain—Niacin—atherosclerosis	0.00116	0.0017	CcSEcCtD
Guanabenz—Body temperature increased—Niacin—atherosclerosis	0.00116	0.0017	CcSEcCtD
Guanabenz—Urticaria—Pravastatin—atherosclerosis	0.00115	0.00168	CcSEcCtD
Guanabenz—Asthenia—Simvastatin—atherosclerosis	0.00115	0.00168	CcSEcCtD
Guanabenz—Diarrhoea—Ezetimibe—atherosclerosis	0.00115	0.00168	CcSEcCtD
Guanabenz—Body temperature increased—Pravastatin—atherosclerosis	0.00115	0.00168	CcSEcCtD
Guanabenz—Abdominal pain—Pravastatin—atherosclerosis	0.00115	0.00168	CcSEcCtD
Guanabenz—Pruritus—Simvastatin—atherosclerosis	0.00114	0.00166	CcSEcCtD
Guanabenz—Dizziness—Lovastatin—atherosclerosis	0.00113	0.00166	CcSEcCtD
Guanabenz—Dizziness—Ezetimibe—atherosclerosis	0.00111	0.00163	CcSEcCtD
Guanabenz—Diarrhoea—Simvastatin—atherosclerosis	0.0011	0.0016	CcSEcCtD
Guanabenz—Vomiting—Lovastatin—atherosclerosis	0.00109	0.00159	CcSEcCtD
Guanabenz—Hypersensitivity—Niacin—atherosclerosis	0.00109	0.00159	CcSEcCtD
Guanabenz—Rash—Lovastatin—atherosclerosis	0.00108	0.00158	CcSEcCtD
Guanabenz—Dermatitis—Lovastatin—atherosclerosis	0.00108	0.00158	CcSEcCtD
Guanabenz—Headache—Lovastatin—atherosclerosis	0.00107	0.00157	CcSEcCtD
Guanabenz—Vomiting—Ezetimibe—atherosclerosis	0.00107	0.00156	CcSEcCtD
Guanabenz—Hypersensitivity—Pravastatin—atherosclerosis	0.00107	0.00156	CcSEcCtD
Guanabenz—Dizziness—Simvastatin—atherosclerosis	0.00106	0.00155	CcSEcCtD
Guanabenz—Rash—Ezetimibe—atherosclerosis	0.00106	0.00155	CcSEcCtD
Guanabenz—Dermatitis—Ezetimibe—atherosclerosis	0.00106	0.00155	CcSEcCtD
Guanabenz—Asthenia—Niacin—atherosclerosis	0.00106	0.00154	CcSEcCtD
Guanabenz—Headache—Ezetimibe—atherosclerosis	0.00105	0.00154	CcSEcCtD
Guanabenz—Pruritus—Niacin—atherosclerosis	0.00104	0.00152	CcSEcCtD
Guanabenz—Asthenia—Pravastatin—atherosclerosis	0.00104	0.00152	CcSEcCtD
Guanabenz—Pruritus—Pravastatin—atherosclerosis	0.00103	0.0015	CcSEcCtD
Guanabenz—Vomiting—Simvastatin—atherosclerosis	0.00102	0.00149	CcSEcCtD
Guanabenz—Nausea—Lovastatin—atherosclerosis	0.00102	0.00149	CcSEcCtD
Guanabenz—Rash—Simvastatin—atherosclerosis	0.00101	0.00148	CcSEcCtD
Guanabenz—Dermatitis—Simvastatin—atherosclerosis	0.00101	0.00148	CcSEcCtD
Guanabenz—Diarrhoea—Niacin—atherosclerosis	0.00101	0.00147	CcSEcCtD
Guanabenz—Headache—Simvastatin—atherosclerosis	0.00101	0.00147	CcSEcCtD
Guanabenz—Nausea—Ezetimibe—atherosclerosis	0.000999	0.00146	CcSEcCtD
Guanabenz—Diarrhoea—Pravastatin—atherosclerosis	0.000993	0.00145	CcSEcCtD
Guanabenz—Dizziness—Niacin—atherosclerosis	0.000974	0.00142	CcSEcCtD
Guanabenz—Dizziness—Pravastatin—atherosclerosis	0.000959	0.0014	CcSEcCtD
Guanabenz—Nausea—Simvastatin—atherosclerosis	0.000953	0.00139	CcSEcCtD
Guanabenz—Vomiting—Niacin—atherosclerosis	0.000937	0.00137	CcSEcCtD
Guanabenz—Rash—Niacin—atherosclerosis	0.000929	0.00136	CcSEcCtD
Guanabenz—Dermatitis—Niacin—atherosclerosis	0.000928	0.00136	CcSEcCtD
Guanabenz—Headache—Niacin—atherosclerosis	0.000923	0.00135	CcSEcCtD
Guanabenz—Vomiting—Pravastatin—atherosclerosis	0.000922	0.00135	CcSEcCtD
Guanabenz—Rash—Pravastatin—atherosclerosis	0.000915	0.00134	CcSEcCtD
Guanabenz—Dermatitis—Pravastatin—atherosclerosis	0.000914	0.00134	CcSEcCtD
Guanabenz—Headache—Pravastatin—atherosclerosis	0.000909	0.00133	CcSEcCtD
Guanabenz—Nausea—Niacin—atherosclerosis	0.000875	0.00128	CcSEcCtD
Guanabenz—Nausea—Pravastatin—atherosclerosis	0.000862	0.00126	CcSEcCtD
Guanabenz—ADRA2C—Signaling by GPCR—F2—atherosclerosis	7.84e-05	0.000248	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling by GPCR—PRKCG—atherosclerosis	7.83e-05	0.000248	CbGpPWpGaD
Guanabenz—ADRA2C—Hemostasis—VEGFA—atherosclerosis	7.82e-05	0.000248	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—VWF—atherosclerosis	7.8e-05	0.000247	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—CYP7A1—atherosclerosis	7.75e-05	0.000246	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—APOC3—atherosclerosis	7.75e-05	0.000245	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—LDLR—atherosclerosis	7.7e-05	0.000244	CbGpPWpGaD
Guanabenz—ADRA2B—Hemostasis—TGFB1—atherosclerosis	7.68e-05	0.000243	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—KNG1—atherosclerosis	7.67e-05	0.000243	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—HMOX1—atherosclerosis	7.66e-05	0.000243	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—AGTR1—atherosclerosis	7.62e-05	0.000241	CbGpPWpGaD
Guanabenz—ADRA2A—GPCR downstream signaling—AGT—atherosclerosis	7.59e-05	0.00024	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—CCL3—atherosclerosis	7.52e-05	0.000238	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling by GPCR—PIK3CG—atherosclerosis	7.5e-05	0.000238	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling by GPCR—CCL2—atherosclerosis	7.48e-05	0.000237	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—PLG—atherosclerosis	7.43e-05	0.000235	CbGpPWpGaD
Guanabenz—ADRA2C—Hemostasis—MAPK3—atherosclerosis	7.39e-05	0.000234	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	7.39e-05	0.000234	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—APOB—atherosclerosis	7.34e-05	0.000232	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—ABCA1—atherosclerosis	7.25e-05	0.00023	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—NCF1—atherosclerosis	7.2e-05	0.000228	CbGpPWpGaD
Guanabenz—ADRA2C—Hemostasis—TGFB1—atherosclerosis	7.17e-05	0.000227	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—CYP27A1—atherosclerosis	7.16e-05	0.000227	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—KNG1—atherosclerosis	7.16e-05	0.000227	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—GSTM1—atherosclerosis	7.14e-05	0.000226	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—AGTR1—atherosclerosis	7.12e-05	0.000226	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	7.05e-05	0.000223	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—SOCS3—atherosclerosis	7.03e-05	0.000223	CbGpPWpGaD
Guanabenz—ADRA2A—GPCR downstream signaling—F2—atherosclerosis	7.01e-05	0.000222	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—LPL—atherosclerosis	7e-05	0.000222	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling by GPCR—CCL2—atherosclerosis	6.99e-05	0.000221	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—PLG—atherosclerosis	6.94e-05	0.00022	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling by GPCR—AGT—atherosclerosis	6.89e-05	0.000218	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	6.88e-05	0.000218	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—GPX1—atherosclerosis	6.83e-05	0.000216	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—CCR2—atherosclerosis	6.8e-05	0.000215	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—EDNRA—atherosclerosis	6.8e-05	0.000215	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—MMP3—atherosclerosis	6.79e-05	0.000215	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—PLA2G2A—atherosclerosis	6.79e-05	0.000215	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—ALOX5AP—atherosclerosis	6.79e-05	0.000215	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—ALOX15—atherosclerosis	6.79e-05	0.000215	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—APOA2—atherosclerosis	6.79e-05	0.000215	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—CYBA—atherosclerosis	6.77e-05	0.000215	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—IGF2—atherosclerosis	6.76e-05	0.000214	CbGpPWpGaD
Guanabenz—ADRA2A—GPCR downstream signaling—PIK3CG—atherosclerosis	6.71e-05	0.000213	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—ABCG5—atherosclerosis	6.71e-05	0.000213	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	6.7e-05	0.000212	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—CD36—atherosclerosis	6.66e-05	0.000211	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—GHRL—atherosclerosis	6.63e-05	0.00021	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—PARP1—atherosclerosis	6.63e-05	0.00021	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—PLAT—atherosclerosis	6.63e-05	0.00021	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—SOCS3—atherosclerosis	6.57e-05	0.000208	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—APOB—atherosclerosis	6.57e-05	0.000208	CbGpPWpGaD
Guanabenz—ADRA2B—GPCR downstream signaling—CXCL8—atherosclerosis	6.51e-05	0.000206	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—LPA—atherosclerosis	6.48e-05	0.000205	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—EDN1—atherosclerosis	6.46e-05	0.000205	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—CCL5—atherosclerosis	6.41e-05	0.000203	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling by GPCR—F2—atherosclerosis	6.37e-05	0.000202	CbGpPWpGaD
Guanabenz—ADRA2A—Hemostasis—VEGFA—atherosclerosis	6.35e-05	0.000201	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—MMP3—atherosclerosis	6.35e-05	0.000201	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—IGF2—atherosclerosis	6.32e-05	0.0002	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—MTHFR—atherosclerosis	6.31e-05	0.0002	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—BGN—atherosclerosis	6.27e-05	0.000199	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—LPL—atherosclerosis	6.27e-05	0.000199	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	6.23e-05	0.000197	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—HMOX1—atherosclerosis	6.22e-05	0.000197	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—APOA5—atherosclerosis	6.21e-05	0.000197	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—PPARA—atherosclerosis	6.19e-05	0.000196	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—APOB—atherosclerosis	6.13e-05	0.000194	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—PRKCG—atherosclerosis	6.1e-05	0.000193	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling by GPCR—PIK3CG—atherosclerosis	6.09e-05	0.000193	CbGpPWpGaD
Guanabenz—ADRA2C—GPCR downstream signaling—CXCL8—atherosclerosis	6.08e-05	0.000193	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—EDN1—atherosclerosis	6.04e-05	0.000191	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	6.03e-05	0.000191	CbGpPWpGaD
Guanabenz—ADRA2A—Hemostasis—MAPK3—atherosclerosis	6.01e-05	0.00019	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—AGT—atherosclerosis	5.99e-05	0.00019	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—CCL5—atherosclerosis	5.99e-05	0.00019	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—PLA2G1B—atherosclerosis	5.98e-05	0.000189	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—APOB—atherosclerosis	5.96e-05	0.000189	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—SPP1—atherosclerosis	5.94e-05	0.000188	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling by GPCR—CXCL8—atherosclerosis	5.91e-05	0.000187	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	5.91e-05	0.000187	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—APOE—atherosclerosis	5.87e-05	0.000186	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—LPL—atherosclerosis	5.86e-05	0.000186	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	5.86e-05	0.000186	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	5.84e-05	0.000185	CbGpPWpGaD
Guanabenz—ADRA2A—Hemostasis—TGFB1—atherosclerosis	5.83e-05	0.000185	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—KNG1—atherosclerosis	5.82e-05	0.000184	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—CAV1—atherosclerosis	5.82e-05	0.000184	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—APOA1—atherosclerosis	5.8e-05	0.000184	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—GSTM1—atherosclerosis	5.8e-05	0.000184	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—AGTR1—atherosclerosis	5.78e-05	0.000183	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—ALOX5—atherosclerosis	5.77e-05	0.000183	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—PRKCG—atherosclerosis	5.69e-05	0.00018	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—LPL—atherosclerosis	5.69e-05	0.00018	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling by GPCR—CCL2—atherosclerosis	5.67e-05	0.00018	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—PLG—atherosclerosis	5.64e-05	0.000179	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—GPX1—atherosclerosis	5.55e-05	0.000176	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—SPP1—atherosclerosis	5.55e-05	0.000176	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling by GPCR—CXCL8—atherosclerosis	5.52e-05	0.000175	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—PDGFB—atherosclerosis	5.49e-05	0.000174	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—CD36—atherosclerosis	5.41e-05	0.000171	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—AGT—atherosclerosis	5.36e-05	0.00017	CbGpPWpGaD
Guanabenz—ADRA2B—Hemostasis—AKT1—atherosclerosis	5.34e-05	0.000169	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—SOCS3—atherosclerosis	5.34e-05	0.000169	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	5.33e-05	0.000169	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—PIK3CG—atherosclerosis	5.3e-05	0.000168	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—LEP—atherosclerosis	5.26e-05	0.000167	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—APOE—atherosclerosis	5.26e-05	0.000167	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—CAV1—atherosclerosis	5.21e-05	0.000165	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—APOA1—atherosclerosis	5.2e-05	0.000165	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—NAMPT—atherosclerosis	5.18e-05	0.000164	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—MMP3—atherosclerosis	5.15e-05	0.000163	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	5.15e-05	0.000163	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—LIPC—atherosclerosis	5.15e-05	0.000163	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—PDGFB—atherosclerosis	5.13e-05	0.000163	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—IGF2—atherosclerosis	5.13e-05	0.000163	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—MTHFR—atherosclerosis	5.12e-05	0.000162	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—APOC3—atherosclerosis	5.11e-05	0.000162	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—PPARG—atherosclerosis	5.11e-05	0.000162	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—LDLR—atherosclerosis	5.08e-05	0.000161	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—PPARA—atherosclerosis	5.03e-05	0.000159	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—ESR1—atherosclerosis	5.02e-05	0.000159	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—INS—atherosclerosis	5.02e-05	0.000159	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—AGT—atherosclerosis	5.01e-05	0.000159	CbGpPWpGaD
Guanabenz—ADRA2C—Hemostasis—AKT1—atherosclerosis	4.99e-05	0.000158	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—APOB—atherosclerosis	4.98e-05	0.000158	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—CETP—atherosclerosis	4.97e-05	0.000157	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—F2—atherosclerosis	4.96e-05	0.000157	CbGpPWpGaD
Guanabenz—ADRA2A—GPCR downstream signaling—CXCL8—atherosclerosis	4.94e-05	0.000156	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—APOE—atherosclerosis	4.91e-05	0.000156	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—LEP—atherosclerosis	4.91e-05	0.000156	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—EDN1—atherosclerosis	4.9e-05	0.000155	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—AGT—atherosclerosis	4.87e-05	0.000154	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—CCL5—atherosclerosis	4.87e-05	0.000154	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—CAV1—atherosclerosis	4.86e-05	0.000154	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—APOA1—atherosclerosis	4.85e-05	0.000154	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—APOE—atherosclerosis	4.77e-05	0.000151	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—LPL—atherosclerosis	4.76e-05	0.000151	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—SCARB1—atherosclerosis	4.75e-05	0.000151	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—PIK3CG—atherosclerosis	4.74e-05	0.00015	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—CAV1—atherosclerosis	4.72e-05	0.00015	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—APOA1—atherosclerosis	4.71e-05	0.000149	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—ESR1—atherosclerosis	4.69e-05	0.000148	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—F2—atherosclerosis	4.63e-05	0.000147	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	4.63e-05	0.000147	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—PRKCG—atherosclerosis	4.63e-05	0.000147	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—ALB—atherosclerosis	4.6e-05	0.000146	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling by GPCR—MAPK3—atherosclerosis	4.54e-05	0.000144	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—SPP1—atherosclerosis	4.51e-05	0.000143	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—HMGCR—atherosclerosis	4.49e-05	0.000142	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—INS—atherosclerosis	4.49e-05	0.000142	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling by GPCR—CXCL8—atherosclerosis	4.49e-05	0.000142	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—PIK3CG—atherosclerosis	4.43e-05	0.00014	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—CCL2—atherosclerosis	4.42e-05	0.00014	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—NOS3—atherosclerosis	4.4e-05	0.000139	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—IGF1—atherosclerosis	4.34e-05	0.000138	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—PIK3CG—atherosclerosis	4.3e-05	0.000136	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling by GPCR—MAPK3—atherosclerosis	4.24e-05	0.000134	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—INS—atherosclerosis	4.19e-05	0.000133	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—PDGFB—atherosclerosis	4.17e-05	0.000132	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—PPARG—atherosclerosis	4.15e-05	0.000132	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—CCL2—atherosclerosis	4.13e-05	0.000131	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—SERPINE1—atherosclerosis	4.12e-05	0.000131	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—INS—atherosclerosis	4.07e-05	0.000129	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—AGT—atherosclerosis	4.07e-05	0.000129	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—IGF1—atherosclerosis	4.06e-05	0.000129	CbGpPWpGaD
Guanabenz—ADRA2A—Hemostasis—AKT1—atherosclerosis	4.05e-05	0.000128	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	4.05e-05	0.000128	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—PTGS2—atherosclerosis	4.02e-05	0.000127	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—ABCA1—atherosclerosis	4e-05	0.000127	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—LEP—atherosclerosis	3.99e-05	0.000126	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—APOE—atherosclerosis	3.99e-05	0.000126	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—CAV1—atherosclerosis	3.95e-05	0.000125	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—APOA1—atherosclerosis	3.94e-05	0.000125	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—NOS3—atherosclerosis	3.94e-05	0.000125	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—SERPINE1—atherosclerosis	3.85e-05	0.000122	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—ESR1—atherosclerosis	3.81e-05	0.000121	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—F2—atherosclerosis	3.76e-05	0.000119	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—ALB—atherosclerosis	3.73e-05	0.000118	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—NOS3—atherosclerosis	3.68e-05	0.000117	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—PIK3CG—atherosclerosis	3.6e-05	0.000114	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—NOS3—atherosclerosis	3.57e-05	0.000113	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—CXCL8—atherosclerosis	3.49e-05	0.000111	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling by GPCR—MAPK3—atherosclerosis	3.45e-05	0.000109	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—HMOX1—atherosclerosis	3.43e-05	0.000109	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—INS—atherosclerosis	3.41e-05	0.000108	CbGpPWpGaD
Guanabenz—ADRA2B—GPCR downstream signaling—AKT1—atherosclerosis	3.37e-05	0.000107	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—CCL2—atherosclerosis	3.35e-05	0.000106	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling by GPCR—IL6—atherosclerosis	3.32e-05	0.000105	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—IGF1—atherosclerosis	3.3e-05	0.000104	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—APOB—atherosclerosis	3.29e-05	0.000104	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—PTGS2—atherosclerosis	3.27e-05	0.000104	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—CXCL8—atherosclerosis	3.26e-05	0.000103	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—GSTM1—atherosclerosis	3.2e-05	0.000101	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—MMP9—atherosclerosis	3.16e-05	0.0001	CbGpPWpGaD
Guanabenz—ADRA2C—GPCR downstream signaling—AKT1—atherosclerosis	3.15e-05	9.98e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—LPL—atherosclerosis	3.14e-05	9.95e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—SERPINE1—atherosclerosis	3.13e-05	9.91e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—NFKB1—atherosclerosis	3.13e-05	9.9e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling by GPCR—IL6—atherosclerosis	3.1e-05	9.83e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—MAPK8—atherosclerosis	3.07e-05	9.73e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—GPX1—atherosclerosis	3.06e-05	9.71e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling by GPCR—AKT1—atherosclerosis	3.06e-05	9.71e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—NOS3—atherosclerosis	2.99e-05	9.46e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—CD36—atherosclerosis	2.98e-05	9.45e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—MMP9—atherosclerosis	2.95e-05	9.35e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—NFKB1—atherosclerosis	2.92e-05	9.25e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—MAPK8—atherosclerosis	2.87e-05	9.09e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling by GPCR—AKT1—atherosclerosis	2.86e-05	9.07e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—VEGFA—atherosclerosis	2.84e-05	8.99e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—MTHFR—atherosclerosis	2.83e-05	8.96e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—STAT3—atherosclerosis	2.81e-05	8.9e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—PPARA—atherosclerosis	2.77e-05	8.79e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—AGT—atherosclerosis	2.69e-05	8.51e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—MAPK3—atherosclerosis	2.68e-05	8.5e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—CXCL8—atherosclerosis	2.65e-05	8.4e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—VEGFA—atherosclerosis	2.65e-05	8.39e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—APOE—atherosclerosis	2.63e-05	8.34e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—STAT3—atherosclerosis	2.62e-05	8.31e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—CAV1—atherosclerosis	2.61e-05	8.26e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—TGFB1—atherosclerosis	2.6e-05	8.25e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—APOA1—atherosclerosis	2.6e-05	8.24e-05	CbGpPWpGaD
Guanabenz—ADRA2A—GPCR downstream signaling—AKT1—atherosclerosis	2.56e-05	8.11e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling by GPCR—IL6—atherosclerosis	2.52e-05	7.98e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—MAPK3—atherosclerosis	2.51e-05	7.94e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—TGFB1—atherosclerosis	2.43e-05	7.7e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—MMP9—atherosclerosis	2.4e-05	7.59e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—PIK3CG—atherosclerosis	2.38e-05	7.53e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—NFKB1—atherosclerosis	2.37e-05	7.51e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—MAPK8—atherosclerosis	2.33e-05	7.38e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling by GPCR—AKT1—atherosclerosis	2.32e-05	7.36e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—PPARG—atherosclerosis	2.29e-05	7.26e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—INS—atherosclerosis	2.25e-05	7.12e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—VEGFA—atherosclerosis	2.15e-05	6.82e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—STAT3—atherosclerosis	2.13e-05	6.75e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—ALB—atherosclerosis	2.06e-05	6.53e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—MAPK3—atherosclerosis	2.04e-05	6.45e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—AKT1—atherosclerosis	2.02e-05	6.41e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—TGFB1—atherosclerosis	1.98e-05	6.26e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—NOS3—atherosclerosis	1.97e-05	6.25e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—IL6—atherosclerosis	1.96e-05	6.22e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—IL6—atherosclerosis	1.83e-05	5.81e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—AKT1—atherosclerosis	1.81e-05	5.73e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—PTGS2—atherosclerosis	1.8e-05	5.71e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—AKT1—atherosclerosis	1.69e-05	5.36e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—AKT1—atherosclerosis	1.64e-05	5.2e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—IL6—atherosclerosis	1.49e-05	4.72e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—AKT1—atherosclerosis	1.37e-05	4.35e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—AKT1—atherosclerosis	9.07e-06	2.87e-05	CbGpPWpGaD
